Our study showed that NO.0449-0145 treatment alone was able to overcome cisplatin resistance in A549-DDP cell and sensitize A549-DDP cells to cisplatin treatment, implying that the inhibition of APE1 by a small-molecule inhibitor may be used to overcome chemotherapeutic resistance in lung cancer treatment. Here, APEX1 is linked to lung cancer.